Analysis of Drug-to-Antibody Ratio in Antibody- Drug Conjugates—Multifaceted Evaluation by LCQTOF and MALDI Analysis—

AS MS 2 0 2 5 , TP 0 3 1 Analysis of an Antibody-Drug Conjugate on a Novel Benchtop MALDI-TOF/TOF Platform Laxmi Sinduri Vuppala1, Guillaume Tremintin2, Sergei Dikler1 1Bruker Scientific LLC, Billerica, MA, USA 2Bruker Scientific LLC, San Jose,…

Analysis of Antibody Drug Conjugate Through the Characterization of Drug Antibody Ratios Using an Agilent 1290 Infinity Binary LC System Coupled to an Agilent 6550 iFunnel Q-TOF Application Note Biopharma Authors Introduction Ravindra Gudihal and Jing Chen Antibody drug conjugates…

Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes Application compendium Contents Introduction3 Featured application notes 2 PLRP-S Polymeric Reversed-Phase Column for LC/MS Separation of mAbs and ADC (5991-7163EN) 5 Intact- and Peptide-Level Characterization of Trastuzumab Emtansine In Vitro…

Size Exclusion Chromatography/ Mass Spectrometry Analysis of Antibody Drug Conjugates Using the Agilent 1260 Infinity II Bio-Inert LC Application Note Biologics & Biosimilars Author Abstract Sonja Schneider Recombinant monoclonal antibodies (mAbs) have emerged as important Agilent Technologies, Inc. therapeutic agents…